Fortrea to Attend Jefferies Global Healthcare Conference
Rhea-AI Summary
Fortrea (Nasdaq: FTRE) will participate in the Jefferies Global Healthcare Conference/b) in New York.CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations Tracy Krumme will join a fireside chat on Thursday, June 4, 2026 at 8:45 AM EDT, with a live webcast and replay available.
Positive
- None.
Negative
- None.
News Market Reaction – FTRE
In the Jun 3 session, FTRE gained 1.76%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 05 | Q1 2026 earnings | Positive | +18.6% | Q1 2026 results with adjusted profitability and reaffirmed 2026 guidance. |
| Apr 21 | Earnings date set | Neutral | -1.1% | Announcement of Q1 2026 release date and conference call logistics. |
| Apr 07 | Tech platform launch | Positive | +5.5% | Launch of Fortrea Intelligent Technology suite for smarter trial execution. |
| Mar 10 | Inducement awards | Neutral | +5.3% | Grants of 130,000 RSUs to new employees under inducement plan. |
| Feb 26 | FY 2025 earnings | Positive | +4.5% | Q4 and 2025 results with guidance and backlog/book-to-bill disclosure. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Shares have often reacted positively to substantial operational and earnings updates, with mixed reactions to scheduling/news items.
Over the past six months, Fortrea has highlighted earnings, technology, and corporate developments. Q4 2025 and full-year results on Feb 26 and Q1 2026 results on May 5 both saw positive price reactions, alongside reaffirmed 2026 guidance and strong backlog metrics. Product and corporate news, such as the Fortrea Intelligent Technology™ launch and inducement awards, also drew mostly positive moves. Today’s Jefferies conference participation fits the pattern of ongoing investor outreach between major financial updates.
Key Terms
cro medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations, Tracy Krumme will participate in the following conference:
Jefferies Global Healthcare Conference (NYC)
Date: Thursday, June 4, 2026
Time: 8:45 AM EDT
Format: Fireside Chat
To register for the live webcast, please click here. A replay will be available in the Events & Presentations section of Fortrea’s Investor Relations website. Investors interested in one-on-one or group meetings should contact their Jefferies representatives.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team, operating across approximately 100 countries, is scaled to deliver focused, agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn, X and Bluesky.
Fortrea Contacts
Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
